Which hedge funds own ADMA? ADMA BIOLOGICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in ADMA (ADMA BIOLOGICS INC) in their Q2 2026 13F filings, worth $196.0m in total. The largest holder by portfolio weight is Rubric Capital Management at 0.7% of its book. 1 manager opened a new position this quarter: Marshall Wace. 1 exited: Tudor Investment.
11tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold ADMA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Rubric Capital Management | Q2 2026 | 0.7% | $78.2m | 9,339,414 | 416% | added |
| Duquesne Family Office LLC | Q2 2026 | 0.5% | $23.3m | 2,784,110 | 80% | added |
| Fundsmith | Q2 2026 | 0.1% | $13.8m | 1,649,493 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $44.1m | 5,274,597 | 841% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $3.4m | 401,059 | -15% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $576.7k | 68,896 | 231% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $5.5m | 652,530 | -48% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $11.5m | 1,370,071 | -76% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $9.7m | 1,154,228 | -66% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $3.5m | 413,935 | -87% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $2.6m | 307,254 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.4% | $6.4m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of ADMA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $196.0m |
| Q1 2026 | 11 | $185.3m |
| Q4 2025 | 8 | $301.9m |
| Q3 2025 | 5 | $193.2m |
| Q2 2025 | 2 | $57.8m |
| Q1 2025 | 2 | $87.2m |
| Q4 2024 | 4 | $69.6m |
| Q3 2024 | 4 | $77.3m |
| Q2 2024 | 5 | $32.5m |
| Q1 2024 | 2 | $15.8m |
| Q4 2023 | 3 | $6.0m |
| Q3 2023 | 2 | $5.6m |
| Q2 2023 | 3 | $5.1m |
| Q1 2023 | 3 | $10.3m |
| Q4 2022 | 3 | $11.3m |
| Q3 2022 | 1 | $1.6m |
Counts every tracked manager that disclosed ADMA in that quarter's filing, including managers that have since stopped filing.